

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.24031065 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.09294050 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.06054860 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 6.06054860 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.64689983 |
| 6 | electron transport chain (GO:0022900) | 5.50944524 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.37035533 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 5.37035533 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.15396741 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.15396741 |
| 11 | fatty acid elongation (GO:0030497) | 4.72730605 |
| 12 | cytochrome complex assembly (GO:0017004) | 4.41174863 |
| 13 | glyoxylate metabolic process (GO:0046487) | 4.14595590 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 4.13830229 |
| 15 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.03299482 |
| 16 | protein-cofactor linkage (GO:0018065) | 4.03135965 |
| 17 | central nervous system myelination (GO:0022010) | 3.96217618 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 3.96217618 |
| 19 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.92225005 |
| 20 | proteasome assembly (GO:0043248) | 3.88028333 |
| 21 | maturation of 5.8S rRNA (GO:0000460) | 3.85510421 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 3.84789951 |
| 23 | L-methionine salvage (GO:0071267) | 3.82111013 |
| 24 | L-methionine biosynthetic process (GO:0071265) | 3.82111013 |
| 25 | amino acid salvage (GO:0043102) | 3.82111013 |
| 26 | branched-chain amino acid catabolic process (GO:0009083) | 3.79344271 |
| 27 | aldehyde catabolic process (GO:0046185) | 3.73815188 |
| 28 | oxidative phosphorylation (GO:0006119) | 3.70422621 |
| 29 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.67307309 |
| 30 | DNA deamination (GO:0045006) | 3.66471708 |
| 31 | bile acid biosynthetic process (GO:0006699) | 3.65817845 |
| 32 | DNA double-strand break processing (GO:0000729) | 3.64213494 |
| 33 | pseudouridine synthesis (GO:0001522) | 3.58664934 |
| 34 | regulation of glucokinase activity (GO:0033131) | 3.57034406 |
| 35 | regulation of hexokinase activity (GO:1903299) | 3.57034406 |
| 36 | rRNA modification (GO:0000154) | 3.57017574 |
| 37 | platelet dense granule organization (GO:0060155) | 3.54799031 |
| 38 | * fatty acid beta-oxidation (GO:0006635) | 3.53884556 |
| 39 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.52154228 |
| 40 | NADH dehydrogenase complex assembly (GO:0010257) | 3.52154228 |
| 41 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.52154228 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.49893920 |
| 43 | * fatty acid catabolic process (GO:0009062) | 3.46116078 |
| 44 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.45227918 |
| 45 | peptidyl-histidine modification (GO:0018202) | 3.44820118 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 3.40917271 |
| 47 | regulation of mitochondrial translation (GO:0070129) | 3.39800328 |
| 48 | ATP biosynthetic process (GO:0006754) | 3.38787768 |
| 49 | aspartate family amino acid catabolic process (GO:0009068) | 3.38173700 |
| 50 | protein complex biogenesis (GO:0070271) | 3.37140456 |
| 51 | * short-chain fatty acid metabolic process (GO:0046459) | 3.36842727 |
| 52 | signal peptide processing (GO:0006465) | 3.36258348 |
| 53 | ketone body metabolic process (GO:1902224) | 3.32455995 |
| 54 | xenobiotic catabolic process (GO:0042178) | 3.32011828 |
| 55 | coenzyme catabolic process (GO:0009109) | 3.31027959 |
| 56 | GPI anchor metabolic process (GO:0006505) | 3.28997333 |
| 57 | cullin deneddylation (GO:0010388) | 3.27499899 |
| 58 | * fatty acid oxidation (GO:0019395) | 3.27240441 |
| 59 | GPI anchor biosynthetic process (GO:0006506) | 3.26654840 |
| 60 | cholesterol biosynthetic process (GO:0006695) | 3.26206342 |
| 61 | chaperone-mediated protein transport (GO:0072321) | 3.25633171 |
| 62 | C-terminal protein lipidation (GO:0006501) | 3.25548961 |
| 63 | S-adenosylmethionine metabolic process (GO:0046500) | 3.25469063 |
| 64 | * lipid oxidation (GO:0034440) | 3.25306396 |
| 65 | * thioester metabolic process (GO:0035383) | 3.24929111 |
| 66 | * acyl-CoA metabolic process (GO:0006637) | 3.24929111 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24465427 |
| 68 | branched-chain amino acid metabolic process (GO:0009081) | 3.23151260 |
| 69 | cysteine metabolic process (GO:0006534) | 3.23147248 |
| 70 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.20049864 |
| 71 | cofactor catabolic process (GO:0051187) | 3.20024133 |
| 72 | * monocarboxylic acid catabolic process (GO:0072329) | 3.19736133 |
| 73 | mannosylation (GO:0097502) | 3.19270528 |
| 74 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.18028538 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.17110722 |
| 76 | protein neddylation (GO:0045116) | 3.16326346 |
| 77 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.15951207 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 3.14434256 |
| 79 | methionine biosynthetic process (GO:0009086) | 3.14393250 |
| 80 | acyl-CoA biosynthetic process (GO:0071616) | 3.12151529 |
| 81 | thioester biosynthetic process (GO:0035384) | 3.12151529 |
| 82 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.11056258 |
| 83 | inner mitochondrial membrane organization (GO:0007007) | 3.09798998 |
| 84 | lysine metabolic process (GO:0006553) | 3.09596034 |
| 85 | lysine catabolic process (GO:0006554) | 3.09596034 |
| 86 | protein deneddylation (GO:0000338) | 3.08736744 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 3.08123778 |
| 88 | tryptophan catabolic process (GO:0006569) | 3.07880085 |
| 89 | indole-containing compound catabolic process (GO:0042436) | 3.07880085 |
| 90 | indolalkylamine catabolic process (GO:0046218) | 3.07880085 |
| 91 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.07393773 |
| 92 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06818187 |
| 93 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06818187 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 3.05703155 |
| 95 | ethanol oxidation (GO:0006069) | 3.05079047 |
| 96 | alpha-linolenic acid metabolic process (GO:0036109) | 3.04722178 |
| 97 | response to pheromone (GO:0019236) | 3.04065005 |
| 98 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.03844020 |
| 99 | heme transport (GO:0015886) | 3.03755921 |
| 100 | hydrogen ion transmembrane transport (GO:1902600) | 3.03220431 |
| 101 | quinone biosynthetic process (GO:1901663) | 3.02524706 |
| 102 | ubiquinone biosynthetic process (GO:0006744) | 3.02524706 |
| 103 | creatine metabolic process (GO:0006600) | 2.99228367 |
| 104 | rRNA methylation (GO:0031167) | 2.97827422 |
| 105 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.96120547 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.95864614 |
| 107 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.95482144 |
| 108 | * fatty-acyl-CoA metabolic process (GO:0035337) | 2.94367075 |
| 109 | C-terminal protein amino acid modification (GO:0018410) | 2.93945220 |
| 110 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.93312916 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.91786275 |
| 112 | * carboxylic acid catabolic process (GO:0046395) | 2.90340912 |
| 113 | * organic acid catabolic process (GO:0016054) | 2.90340912 |
| 114 | aerobic respiration (GO:0009060) | 2.90238645 |
| 115 | glutathione metabolic process (GO:0006749) | 2.89032225 |
| 116 | glutathione derivative biosynthetic process (GO:1901687) | 2.88315705 |
| 117 | glutathione derivative metabolic process (GO:1901685) | 2.88315705 |
| 118 | alpha-amino acid catabolic process (GO:1901606) | 2.87780259 |
| 119 | bile acid metabolic process (GO:0008206) | 2.87476542 |
| 120 | sterol biosynthetic process (GO:0016126) | 2.87341574 |
| 121 | inositol phosphate catabolic process (GO:0071545) | 2.87293889 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.85732032 |
| 123 | adenosine metabolic process (GO:0046085) | 2.85123964 |
| 124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84981371 |
| 125 | termination of RNA polymerase III transcription (GO:0006386) | 2.84981371 |
| 126 | cellular amino acid catabolic process (GO:0009063) | 2.83477291 |
| 127 | regulation of cholesterol metabolic process (GO:0090181) | 2.83247603 |
| 128 | ubiquinone metabolic process (GO:0006743) | 2.83235054 |
| 129 | regulation of cilium movement (GO:0003352) | 2.82263221 |
| 130 | proton transport (GO:0015992) | 2.80314621 |
| 131 | tyrosine metabolic process (GO:0006570) | 2.78567288 |
| 132 | hydrogen transport (GO:0006818) | 2.78016075 |
| 133 | tricarboxylic acid cycle (GO:0006099) | 2.77929123 |
| 134 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.77397179 |
| 135 | low-density lipoprotein particle remodeling (GO:0034374) | 2.77163345 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.77066245 |
| 137 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76972527 |
| 138 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.76441030 |
| 139 | quinone metabolic process (GO:1901661) | 2.71667625 |
| 140 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.71537329 |
| 141 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.70195365 |
| 142 | ethanol metabolic process (GO:0006067) | 2.70118500 |
| 143 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.69274126 |
| 144 | ribosome assembly (GO:0042255) | 2.69013916 |
| 145 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.67885695 |
| 146 | glutathione biosynthetic process (GO:0006750) | 2.67312653 |
| 147 | cellular respiration (GO:0045333) | 2.66619624 |
| 148 | methionine metabolic process (GO:0006555) | 2.66462517 |
| 149 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.64536911 |
| 150 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64505735 |
| 151 | nucleotide transmembrane transport (GO:1901679) | 2.64448597 |
| 152 | carnitine metabolic process (GO:0009437) | 2.64289866 |
| 153 | respiratory chain complex IV assembly (GO:0008535) | 2.62358408 |
| 154 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.61920944 |
| 155 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61920944 |
| 156 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.61920944 |
| 157 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.60467658 |
| 158 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.58697048 |
| 159 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.58697048 |
| 160 | synapsis (GO:0007129) | 2.58373932 |
| 161 | valine metabolic process (GO:0006573) | 2.57640618 |
| 162 | lactate metabolic process (GO:0006089) | 2.57124468 |
| 163 | protein targeting to mitochondrion (GO:0006626) | 2.56182972 |
| 164 | polyol catabolic process (GO:0046174) | 2.56070671 |
| 165 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.55465332 |
| 166 | tRNA processing (GO:0008033) | 2.54819949 |
| 167 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.54343111 |
| 168 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.52823473 |
| 169 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.51646310 |
| 170 | inositol phosphate dephosphorylation (GO:0046855) | 2.51646310 |
| 171 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.51522407 |
| 172 | histone H2A acetylation (GO:0043968) | 2.50187655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.58898547 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94914776 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.34028109 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.10120271 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.03453926 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.49500322 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.41260760 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40921507 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21116685 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.08189013 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06608630 |
| 12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.70346500 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.62186558 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.50969715 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.50544985 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.39956786 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.37740082 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15158667 |
| 19 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.13937002 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07380821 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03191050 |
| 22 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01450184 |
| 23 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.98687712 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98400729 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.98324566 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93667599 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.93145226 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91027949 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.89737724 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88552836 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86814389 |
| 32 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.81309228 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74737182 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74644400 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74520763 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.69180370 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.68012306 |
| 38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.66706584 |
| 39 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60302316 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58193370 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56998262 |
| 42 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.53823407 |
| 43 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53088083 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53063509 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52104598 |
| 46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48844444 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48076525 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46678543 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.42750077 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40872464 |
| 51 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36650418 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35671058 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34442723 |
| 54 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30471928 |
| 55 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30471928 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29765283 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29765283 |
| 58 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29172246 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29013408 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28242455 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25099561 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25099561 |
| 63 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25046728 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21049254 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19958341 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18691344 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16413852 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16383211 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12529816 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11398539 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11135122 |
| 72 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10604589 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09562398 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09242573 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05950057 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05398982 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04632107 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04162193 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02785887 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02582065 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01413629 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99278891 |
| 83 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99000725 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98821463 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98609492 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97772802 |
| 87 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97405841 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97383206 |
| 89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96742512 |
| 90 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96268944 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94303384 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93895045 |
| 93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93384309 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92859249 |
| 95 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92237009 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91394739 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90440321 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90359188 |
| 99 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90323190 |
| 100 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90101991 |
| 101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89592977 |
| 102 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89018652 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88856224 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88769058 |
| 105 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88506900 |
| 106 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88505452 |
| 107 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88146452 |
| 108 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.88089863 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88055369 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87464839 |
| 111 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86986450 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86968412 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86448801 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85891033 |
| 115 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84371747 |
| 116 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83759804 |
| 117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83612206 |
| 118 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83612206 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82094508 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80682624 |
| 121 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79521180 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79265430 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79083721 |
| 124 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78724867 |
| 125 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.77041873 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76830209 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75914930 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74371038 |
| 129 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.73448792 |
| 130 | NCOR_22424771_ChIP-Seq_293T_Human | 0.73317504 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.72232142 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71177772 |
| 133 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.70951149 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68728673 |
| 135 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.68043757 |
| 136 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.67399211 |
| 137 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.67183968 |
| 138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.67114109 |
| 139 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.65866179 |
| 140 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65750067 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.64986999 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.64906624 |
| 143 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.64891238 |
| 144 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.64335231 |
| 145 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64328464 |
| 146 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.64161410 |
| 147 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.64110344 |
| 148 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.63726099 |
| 149 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.63084698 |
| 150 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.62498501 |
| 151 | FUS_26573619_Chip-Seq_HEK293_Human | 0.61571250 |
| 152 | P300_19829295_ChIP-Seq_ESCs_Human | 0.60999688 |
| 153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.59542328 |
| 154 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.59097550 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58314698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.36997141 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.34195885 |
| 3 | MP0005360_urolithiasis | 4.20654455 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.99996305 |
| 5 | MP0005365_abnormal_bile_salt | 3.76665551 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.57589915 |
| 7 | MP0003195_calcinosis | 3.38621989 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.93780578 |
| 9 | MP0005332_abnormal_amino_acid | 2.58713679 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.52018523 |
| 11 | MP0008058_abnormal_DNA_repair | 2.49947386 |
| 12 | MP0005451_abnormal_body_composition | 2.38275241 |
| 13 | MP0003646_muscle_fatigue | 2.35827452 |
| 14 | MP0003186_abnormal_redox_activity | 2.31858596 |
| 15 | MP0002163_abnormal_gland_morphology | 2.30101296 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.29422351 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.21232984 |
| 18 | MP0004043_abnormal_pH_regulation | 2.14691004 |
| 19 | MP0005083_abnormal_biliary_tract | 2.12622792 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.08884162 |
| 21 | MP0003786_premature_aging | 2.03797273 |
| 22 | MP0001529_abnormal_vocalization | 2.00676209 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 2.00185623 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.98708513 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.88960602 |
| 26 | MP0009840_abnormal_foam_cell | 1.86949571 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.86032488 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.84550224 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.84170675 |
| 30 | MP0009697_abnormal_copulation | 1.82391910 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.79915171 |
| 32 | MP0000920_abnormal_myelination | 1.79859172 |
| 33 | MP0001984_abnormal_olfaction | 1.79326279 |
| 34 | MP0002102_abnormal_ear_morphology | 1.79259612 |
| 35 | MP0000749_muscle_degeneration | 1.76241867 |
| 36 | MP0004147_increased_porphyrin_level | 1.70509439 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.68317830 |
| 38 | MP0008995_early_reproductive_senescence | 1.67942274 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.66425317 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65887262 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.65020172 |
| 42 | MP0001764_abnormal_homeostasis | 1.60327033 |
| 43 | MP0005253_abnormal_eye_physiology | 1.56861821 |
| 44 | MP0001905_abnormal_dopamine_level | 1.52030257 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.51570806 |
| 46 | MP0005330_cardiomyopathy | 1.49883310 |
| 47 | MP0000516_abnormal_urinary_system | 1.49400628 |
| 48 | MP0005367_renal/urinary_system_phenotyp | 1.49400628 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.48005127 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.47239069 |
| 51 | MP0002132_abnormal_respiratory_system | 1.44048240 |
| 52 | MP0003283_abnormal_digestive_organ | 1.43442491 |
| 53 | MP0003252_abnormal_bile_duct | 1.42503285 |
| 54 | MP0005670_abnormal_white_adipose | 1.42018492 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.41750904 |
| 56 | MP0003011_delayed_dark_adaptation | 1.40836036 |
| 57 | MP0003690_abnormal_glial_cell | 1.39244407 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.38676165 |
| 59 | MP0001944_abnormal_pancreas_morphology | 1.37144604 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.36788701 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.36598871 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.35658822 |
| 63 | MP0006054_spinal_hemorrhage | 1.34097786 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.33521438 |
| 65 | MP0002938_white_spotting | 1.31606624 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.31125233 |
| 67 | MP0004142_abnormal_muscle_tone | 1.30266729 |
| 68 | MP0005410_abnormal_fertilization | 1.27687896 |
| 69 | MP0000751_myopathy | 1.25183440 |
| 70 | MP0005408_hypopigmentation | 1.24413021 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.24269955 |
| 72 | MP0005535_abnormal_body_temperature | 1.22402247 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.22030722 |
| 74 | MP0002693_abnormal_pancreas_physiology | 1.20650653 |
| 75 | MP0002254_reproductive_system_inflammat | 1.17889464 |
| 76 | MP0002090_abnormal_vision | 1.17588837 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.15206157 |
| 78 | MP0010094_abnormal_chromosome_stability | 1.14067509 |
| 79 | MP0003136_yellow_coat_color | 1.13068461 |
| 80 | MP0005165_increased_susceptibility_to | 1.12751186 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.10279083 |
| 82 | MP0003329_amyloid_beta_deposits | 1.10125029 |
| 83 | MP0005266_abnormal_metabolism | 1.08449231 |
| 84 | MP0004381_abnormal_hair_follicle | 1.05888756 |
| 85 | MP0000609_abnormal_liver_physiology | 1.04293300 |
| 86 | MP0000230_abnormal_systemic_arterial | 1.04199294 |
| 87 | MP0008789_abnormal_olfactory_epithelium | 1.03993334 |
| 88 | MP0003724_increased_susceptibility_to | 1.03973373 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 1.01369540 |
| 90 | MP0004130_abnormal_muscle_cell | 1.00359253 |
| 91 | MP0002822_catalepsy | 0.98281019 |
| 92 | MP0002928_abnormal_bile_duct | 0.95914150 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.94146454 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.93528635 |
| 95 | MP0005620_abnormal_muscle_contractility | 0.92995537 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.91544927 |
| 97 | MP0002160_abnormal_reproductive_system | 0.91369919 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.91109873 |
| 99 | MP0001929_abnormal_gametogenesis | 0.89287373 |
| 100 | MP0000604_amyloidosis | 0.87925196 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 0.86746377 |
| 102 | MP0003868_abnormal_feces_composition | 0.86310672 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.84703499 |
| 104 | MP0004134_abnormal_chest_morphology | 0.84276404 |
| 105 | MP0000358_abnormal_cell_content/ | 0.83806004 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.83475640 |
| 107 | MP0001661_extended_life_span | 0.82977861 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.82354026 |
| 109 | MP0004484_altered_response_of | 0.82059671 |
| 110 | MP0000747_muscle_weakness | 0.81856374 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.80302861 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.80302861 |
| 113 | MP0000653_abnormal_sex_gland | 0.80160849 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.79752191 |
| 115 | MP0004085_abnormal_heartbeat | 0.79160073 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.79109067 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 0.78685935 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.78304120 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.76689993 |
| 120 | MP0000427_abnormal_hair_cycle | 0.75865116 |
| 121 | MP0009046_muscle_twitch | 0.75261880 |
| 122 | MP0001145_abnormal_male_reproductive | 0.74657638 |
| 123 | MP0004133_heterotaxia | 0.74592633 |
| 124 | MP0001756_abnormal_urination | 0.74414700 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.74290524 |
| 126 | MP0002210_abnormal_sex_determination | 0.74244513 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.74111186 |
| 128 | MP0002095_abnormal_skin_pigmentation | 0.73662123 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.73203344 |
| 130 | MP0006138_congestive_heart_failure | 0.72023650 |
| 131 | MP0005647_abnormal_sex_gland | 0.71143179 |
| 132 | MP0002971_abnormal_brown_adipose | 0.71022702 |
| 133 | MP0005389_reproductive_system_phenotype | 0.70962711 |
| 134 | MP0000343_altered_response_to | 0.70864245 |
| 135 | MP0005075_abnormal_melanosome_morpholog | 0.70733402 |
| 136 | MP0003718_maternal_effect | 0.70239709 |
| 137 | MP0008469_abnormal_protein_level | 0.69927514 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.68747145 |
| 139 | MP0003880_abnormal_central_pattern | 0.68398089 |
| 140 | MP0001440_abnormal_grooming_behavior | 0.68341150 |
| 141 | MP0005409_darkened_coat_color | 0.68207654 |
| 142 | MP0002106_abnormal_muscle_physiology | 0.68043204 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.67422224 |
| 144 | MP0002909_abnormal_adrenal_gland | 0.67301820 |
| 145 | MP0003698_abnormal_male_reproductive | 0.66791964 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.66513355 |
| 147 | MP0009763_increased_sensitivity_to | 0.65947575 |
| 148 | MP0005395_other_phenotype | 0.65880332 |
| 149 | MP0002638_abnormal_pupillary_reflex | 0.65872340 |
| 150 | MP0004885_abnormal_endolymph | 0.65699787 |
| 151 | MP0009642_abnormal_blood_homeostasis | 0.65194603 |
| 152 | MP0008872_abnormal_physiological_respon | 0.62658970 |
| 153 | MP0002229_neurodegeneration | 0.61454375 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.60801394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.33042468 |
| 2 | Acute encephalopathy (HP:0006846) | 5.12318748 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.96941301 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.68585803 |
| 5 | Hepatic necrosis (HP:0002605) | 4.67040031 |
| 6 | Cerebral edema (HP:0002181) | 4.47566875 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.44139328 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.39301821 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.38217083 |
| 10 | Increased CSF lactate (HP:0002490) | 4.15859413 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 4.10578655 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.94320806 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.89388275 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.68891685 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.61186645 |
| 16 | Increased serum pyruvate (HP:0003542) | 3.54154705 |
| 17 | Abnormality of glycolysis (HP:0004366) | 3.54154705 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 3.52860610 |
| 19 | Increased muscle lipid content (HP:0009058) | 3.52164351 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46446669 |
| 21 | Lactic acidosis (HP:0003128) | 3.33949180 |
| 22 | Ketosis (HP:0001946) | 3.31631375 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.26163304 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.25433658 |
| 25 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.24095488 |
| 26 | * Dicarboxylic aciduria (HP:0003215) | 3.24095488 |
| 27 | Lethargy (HP:0001254) | 3.13845558 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 3.12004205 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.10724570 |
| 30 | Glycosuria (HP:0003076) | 3.10724570 |
| 31 | Respiratory failure (HP:0002878) | 3.05759343 |
| 32 | Abnormality of the renal cortex (HP:0011035) | 3.04811047 |
| 33 | Ketoacidosis (HP:0001993) | 3.04311550 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.03437988 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.03437988 |
| 36 | Leukodystrophy (HP:0002415) | 3.01613913 |
| 37 | Hyperammonemia (HP:0001987) | 2.97306916 |
| 38 | Exercise intolerance (HP:0003546) | 2.92208688 |
| 39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.90824268 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 2.90824268 |
| 41 | Hyperalaninemia (HP:0003348) | 2.90824268 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.90505980 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.88656395 |
| 44 | Xanthomatosis (HP:0000991) | 2.87997347 |
| 45 | Hyperglycinuria (HP:0003108) | 2.83856178 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83203553 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79352489 |
| 48 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79352489 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.78675305 |
| 50 | Increased serum lactate (HP:0002151) | 2.78089116 |
| 51 | Pancreatic cysts (HP:0001737) | 2.74022467 |
| 52 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.73601587 |
| 53 | Hyperglycinemia (HP:0002154) | 2.72951394 |
| 54 | Optic disc pallor (HP:0000543) | 2.70181609 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.65173689 |
| 56 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62935749 |
| 57 | Hypothermia (HP:0002045) | 2.59788246 |
| 58 | Vomiting (HP:0002013) | 2.59668923 |
| 59 | Abnormality of renal resorption (HP:0011038) | 2.58523028 |
| 60 | Calf muscle hypertrophy (HP:0008981) | 2.54694009 |
| 61 | Parakeratosis (HP:0001036) | 2.51178215 |
| 62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.49309204 |
| 63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.49309204 |
| 64 | Abnormal protein glycosylation (HP:0012346) | 2.49309204 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.49309204 |
| 66 | Type I transferrin isoform profile (HP:0003642) | 2.47743313 |
| 67 | Exertional dyspnea (HP:0002875) | 2.46621833 |
| 68 | Deep venous thrombosis (HP:0002625) | 2.45568007 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43995807 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.42566109 |
| 71 | * Metabolic acidosis (HP:0001942) | 2.41804661 |
| 72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35277254 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.35136045 |
| 74 | True hermaphroditism (HP:0010459) | 2.34116335 |
| 75 | Fat malabsorption (HP:0002630) | 2.33363116 |
| 76 | Abnormality of methionine metabolism (HP:0010901) | 2.33017482 |
| 77 | Cerebral hemorrhage (HP:0001342) | 2.32113236 |
| 78 | CNS demyelination (HP:0007305) | 2.28579831 |
| 79 | Nephronophthisis (HP:0000090) | 2.28235890 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.27482024 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.27482024 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.27389618 |
| 83 | Myoglobinuria (HP:0002913) | 2.25339335 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.24586820 |
| 85 | * Abnormality of vitamin B metabolism (HP:0004340) | 2.24328461 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.22762299 |
| 87 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.21246176 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.20606296 |
| 89 | Pheochromocytoma (HP:0002666) | 2.20153675 |
| 90 | * Methylmalonic aciduria (HP:0012120) | 2.19987323 |
| 91 | Steatorrhea (HP:0002570) | 2.19431600 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17297966 |
| 93 | Thyroiditis (HP:0100646) | 2.16063491 |
| 94 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13145197 |
| 95 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13145197 |
| 96 | Abnormality of serum amino acid levels (HP:0003112) | 2.12048515 |
| 97 | Respiratory difficulties (HP:0002880) | 2.09616458 |
| 98 | Spastic paraparesis (HP:0002313) | 2.08940140 |
| 99 | Gait imbalance (HP:0002141) | 2.07968602 |
| 100 | Abnormality of the renal medulla (HP:0100957) | 2.06904078 |
| 101 | Nausea (HP:0002018) | 2.01989452 |
| 102 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01631251 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.01187567 |
| 104 | * Methylmalonic acidemia (HP:0002912) | 2.00796818 |
| 105 | Palpitations (HP:0001962) | 1.98992452 |
| 106 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.96332087 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 1.96233923 |
| 108 | Microvesicular hepatic steatosis (HP:0001414) | 1.96091076 |
| 109 | X-linked dominant inheritance (HP:0001423) | 1.95946710 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.95659241 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 1.95659241 |
| 112 | Abnormal urine phosphate concentration (HP:0012599) | 1.95086227 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94496455 |
| 114 | Hyperbilirubinemia (HP:0002904) | 1.94314644 |
| 115 | Severe combined immunodeficiency (HP:0004430) | 1.93807041 |
| 116 | Neurofibrillary tangles (HP:0002185) | 1.90496668 |
| 117 | Hypolipoproteinemia (HP:0010981) | 1.88445135 |
| 118 | Hyperglycemia (HP:0003074) | 1.86329146 |
| 119 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85676833 |
| 120 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85676833 |
| 121 | Hypoproteinemia (HP:0003075) | 1.84857467 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84616626 |
| 123 | Abnormality of the anterior horn cell (HP:0006802) | 1.84526394 |
| 124 | Degeneration of anterior horn cells (HP:0002398) | 1.84526394 |
| 125 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83908626 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 1.82078417 |
| 127 | Cholecystitis (HP:0001082) | 1.82078417 |
| 128 | Renal cortical cysts (HP:0000803) | 1.79563728 |
| 129 | Large for gestational age (HP:0001520) | 1.78187860 |
| 130 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77876319 |
| 131 | Rhabdomyolysis (HP:0003201) | 1.77056861 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.76429647 |
| 133 | Respiratory distress (HP:0002098) | 1.76363525 |
| 134 | Renal tubular dysfunction (HP:0000124) | 1.75566669 |
| 135 | Brushfield spots (HP:0001088) | 1.75448573 |
| 136 | Albinism (HP:0001022) | 1.74587497 |
| 137 | * Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74490936 |
| 138 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74356776 |
| 139 | Complement deficiency (HP:0004431) | 1.73981194 |
| 140 | Abnormal biliary tract physiology (HP:0012439) | 1.73449672 |
| 141 | Bile duct proliferation (HP:0001408) | 1.73449672 |
| 142 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.73387511 |
| 143 | Poor head control (HP:0002421) | 1.69634862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.60162237 |
| 2 | STK39 | 4.09656640 |
| 3 | FRK | 3.72758904 |
| 4 | OXSR1 | 3.16820888 |
| 5 | NUAK1 | 2.80481483 |
| 6 | WNK4 | 2.77975674 |
| 7 | NME2 | 2.77871764 |
| 8 | MYLK | 2.72771100 |
| 9 | EIF2AK1 | 2.68973753 |
| 10 | STK16 | 2.68636804 |
| 11 | MUSK | 2.58706390 |
| 12 | MST4 | 2.58500052 |
| 13 | NEK1 | 2.37197728 |
| 14 | ARAF | 2.28953597 |
| 15 | MAP4K2 | 2.27359213 |
| 16 | OBSCN | 2.17365108 |
| 17 | PBK | 2.15291164 |
| 18 | MAPKAPK5 | 2.09910554 |
| 19 | ZAK | 2.09376956 |
| 20 | INSRR | 2.00997702 |
| 21 | VRK2 | 1.98658132 |
| 22 | GRK7 | 1.83980118 |
| 23 | MAP3K4 | 1.71525458 |
| 24 | PKN1 | 1.70196503 |
| 25 | PIM2 | 1.66196958 |
| 26 | PIK3CG | 1.61983848 |
| 27 | PLK2 | 1.59163025 |
| 28 | BCR | 1.58149179 |
| 29 | SRPK1 | 1.52706648 |
| 30 | CDK19 | 1.44671730 |
| 31 | MAPK15 | 1.44232430 |
| 32 | AKT3 | 1.40044089 |
| 33 | TNIK | 1.35302296 |
| 34 | TIE1 | 1.33075987 |
| 35 | PHKG2 | 1.30640769 |
| 36 | PHKG1 | 1.30640769 |
| 37 | CAMK2D | 1.29351719 |
| 38 | PDK2 | 1.23157431 |
| 39 | NME1 | 1.20552173 |
| 40 | PLK3 | 1.19973286 |
| 41 | EPHB1 | 1.19223835 |
| 42 | TRIM28 | 1.19055550 |
| 43 | TLK1 | 1.18916532 |
| 44 | ERBB3 | 1.18395357 |
| 45 | PIK3CA | 1.15680954 |
| 46 | CASK | 1.15115174 |
| 47 | PLK4 | 1.14875335 |
| 48 | PINK1 | 1.11183937 |
| 49 | BUB1 | 1.10880443 |
| 50 | PASK | 1.08892935 |
| 51 | MAP3K3 | 1.05886627 |
| 52 | ABL2 | 1.05742529 |
| 53 | CAMK2G | 1.05330161 |
| 54 | TNK2 | 1.04236858 |
| 55 | GRK1 | 1.03991474 |
| 56 | BMPR1B | 1.02211645 |
| 57 | ADRBK2 | 0.99776192 |
| 58 | IRAK3 | 0.99561396 |
| 59 | CSNK1G3 | 0.99349891 |
| 60 | TXK | 0.97716223 |
| 61 | TSSK6 | 0.94870872 |
| 62 | MAPKAPK3 | 0.93957882 |
| 63 | LMTK2 | 0.93728630 |
| 64 | MAP3K12 | 0.93641428 |
| 65 | BRSK2 | 0.91837426 |
| 66 | EIF2AK2 | 0.91624794 |
| 67 | STK38L | 0.90796494 |
| 68 | BMPR2 | 0.90302269 |
| 69 | CAMK2B | 0.90297770 |
| 70 | ACVR1B | 0.89515001 |
| 71 | LIMK1 | 0.88967165 |
| 72 | KDR | 0.88795418 |
| 73 | MAPK12 | 0.88782688 |
| 74 | MAPK13 | 0.88514567 |
| 75 | WNK3 | 0.88297225 |
| 76 | PDK4 | 0.86846394 |
| 77 | PDK3 | 0.86846394 |
| 78 | FGFR2 | 0.85953644 |
| 79 | CAMK2A | 0.82121942 |
| 80 | NEK6 | 0.81436616 |
| 81 | VRK1 | 0.81327074 |
| 82 | TTK | 0.81094899 |
| 83 | MAP2K6 | 0.78569529 |
| 84 | PRKCE | 0.76395882 |
| 85 | TBK1 | 0.74815640 |
| 86 | MKNK2 | 0.74813727 |
| 87 | PRKCQ | 0.72738423 |
| 88 | FLT3 | 0.71735780 |
| 89 | CDK8 | 0.70560128 |
| 90 | RPS6KA4 | 0.69995214 |
| 91 | DAPK3 | 0.69814123 |
| 92 | MAPK4 | 0.69154737 |
| 93 | BRAF | 0.67578892 |
| 94 | CSNK1G1 | 0.67004825 |
| 95 | STK24 | 0.65859642 |
| 96 | TEC | 0.65270675 |
| 97 | STK3 | 0.64373303 |
| 98 | ILK | 0.63595613 |
| 99 | TRPM7 | 0.60073526 |
| 100 | TGFBR1 | 0.59174073 |
| 101 | FER | 0.58896712 |
| 102 | MET | 0.58800682 |
| 103 | WEE1 | 0.58325892 |
| 104 | ROCK2 | 0.57508231 |
| 105 | PRKACA | 0.57286879 |
| 106 | MAP2K7 | 0.56844465 |
| 107 | IRAK4 | 0.56760817 |
| 108 | TESK2 | 0.56688721 |
| 109 | CSNK1G2 | 0.56279306 |
| 110 | ADRBK1 | 0.55282165 |
| 111 | TTN | 0.54999904 |
| 112 | PRKD1 | 0.54301083 |
| 113 | CLK1 | 0.51760267 |
| 114 | PRKCG | 0.51112125 |
| 115 | MST1R | 0.50482770 |
| 116 | ERBB4 | 0.50413754 |
| 117 | PDPK1 | 0.49674731 |
| 118 | CSNK2A2 | 0.49628158 |
| 119 | EPHA3 | 0.49628126 |
| 120 | IKBKE | 0.49051219 |
| 121 | RPS6KA5 | 0.48519985 |
| 122 | EIF2AK3 | 0.48375815 |
| 123 | ATM | 0.48324408 |
| 124 | MKNK1 | 0.48262640 |
| 125 | PLK1 | 0.48187561 |
| 126 | PRKCI | 0.47222164 |
| 127 | ATR | 0.47166809 |
| 128 | MAP2K3 | 0.46820778 |
| 129 | PAK3 | 0.46663727 |
| 130 | PRKACB | 0.44394549 |
| 131 | DYRK2 | 0.43459972 |
| 132 | KIT | 0.42835723 |
| 133 | IKBKB | 0.42733114 |
| 134 | CSNK2A1 | 0.42259797 |
| 135 | GRK5 | 0.41882475 |
| 136 | PRKAA2 | 0.41811352 |
| 137 | WNK1 | 0.41089511 |
| 138 | DAPK1 | 0.40779857 |
| 139 | PRKG1 | 0.40770886 |
| 140 | UHMK1 | 0.40346587 |
| 141 | PRKG2 | 0.39465084 |
| 142 | MAP2K2 | 0.39433374 |
| 143 | DAPK2 | 0.38922865 |
| 144 | PTK2B | 0.37053616 |
| 145 | STK4 | 0.35818178 |
| 146 | CAMK1 | 0.35700666 |
| 147 | PNCK | 0.35632470 |
| 148 | SGK223 | 0.35576675 |
| 149 | SGK494 | 0.35576675 |
| 150 | CSNK1A1 | 0.35166634 |
| 151 | PRKCA | 0.35032485 |
| 152 | TAOK3 | 0.33931940 |
| 153 | PRPF4B | 0.33618853 |
| 154 | CSNK1A1L | 0.32982405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.83780461 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.19270969 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97803959 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61373169 |
| 5 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58737705 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56924941 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51414342 |
| 8 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.49555031 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.42027923 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.31418086 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29909484 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.22041921 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.10175354 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.06438216 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.04572407 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03114956 |
| 17 | Protein export_Homo sapiens_hsa03060 | 2.00876151 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99381220 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.99111521 |
| 20 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97797629 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91749723 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89902458 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86910146 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85812992 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.85366492 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.79648335 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.79545210 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75788930 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70405491 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63224485 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.63085003 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61645634 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58008086 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57649718 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55820383 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51164272 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48579126 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45304701 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.44864445 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.43620042 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39439146 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37975608 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37113855 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35792720 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35386764 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34105987 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.32489747 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30938387 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30088494 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27816882 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27789131 |
| 52 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.25113498 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24007161 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21629131 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20163176 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17129459 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 1.14917568 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13986221 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11449262 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.08031265 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07721556 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 1.06727735 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00280267 |
| 64 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.97678788 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91644938 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90559816 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89199254 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84326214 |
| 69 | RNA transport_Homo sapiens_hsa03013 | 0.84052059 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81678522 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80015359 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.79763177 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79365298 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78934863 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78807570 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77777304 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77555608 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76492543 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76468758 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72410260 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71430443 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70681091 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70415416 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67002900 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66890538 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65098979 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61465489 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.61298992 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61129667 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.58287722 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57563971 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56934904 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.54015800 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.53030292 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51412870 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49993138 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.49479484 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47703714 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44651042 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42147720 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38319056 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36730694 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36004401 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35546529 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31347027 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29885627 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.26893093 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25750214 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25272045 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21752819 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21321730 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.17829514 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.16103708 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15515667 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12906886 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11107816 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.10350674 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.08337660 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.04782993 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04674621 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04116778 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03988707 |

